These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 9815963

  • 1. Expression of the multiple drug resistance gene in human renal cell carcinoma depends on tumor histology, grade, and stage.
    Tobe SW, Noble-Topham SE, Andrulis IL, Hartwick RW, Skorecki KL, Warner E.
    Clin Cancer Res; 1995 Dec; 1(12):1611-5. PubMed ID: 9815963
    [Abstract] [Full Text] [Related]

  • 2. Expression of genes involved in chemoresistance, proliferation and apoptosis in clinical samples of renal cell carcinoma and correlation with clinical outcome.
    Oudard S, Levalois C, Andrieu JM, Bougaran J, Validire P, Thiounn N, Poupon MF, Fourme E, Chevillard S.
    Anticancer Res; 2002 Dec; 22(1A):121-8. PubMed ID: 12017273
    [Abstract] [Full Text] [Related]

  • 3. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A, Paner GP, Skinnider BF, Cohen C, Datta MW, Young AN, Srigley JR, Amin MB.
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [Abstract] [Full Text] [Related]

  • 4. Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors.
    Costa VL, Henrique R, Ribeiro FR, Pinto M, Oliveira J, Lobo F, Teixeira MR, Jerónimo C.
    BMC Cancer; 2007 Jul 23; 7():133. PubMed ID: 17645803
    [Abstract] [Full Text] [Related]

  • 5. Absence or reduction of Fhit expression in most clear cell renal carcinomas.
    Hadaczek P, Siprashvili Z, Markiewski M, Domagala W, Druck T, McCue PA, Pekarsky Y, Ohta M, Huebner K, Lubinski J.
    Cancer Res; 1998 Jul 15; 58(14):2946-51. PubMed ID: 9679951
    [Abstract] [Full Text] [Related]

  • 6. Differential expression of caveolin-1 in renal neoplasms.
    Tamaskar I, Choueiri TK, Sercia L, Rini B, Bukowski R, Zhou M.
    Cancer; 2007 Aug 15; 110(4):776-82. PubMed ID: 17594718
    [Abstract] [Full Text] [Related]

  • 7. Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas.
    Cheung C, Vesey D, Cotterill A, Douglas M, Gobe G, Nicol D, Johnson D.
    Int J Urol; 2005 Jan 15; 12(1):17-28. PubMed ID: 15661050
    [Abstract] [Full Text] [Related]

  • 8. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L, Sugimura J, Tretiakova MS, Patton KT, Gupta R, Popov B, Laskin WB, Yeldandi A, Teh BT, Yang XJ.
    Hum Pathol; 2005 Mar 15; 36(3):262-8. PubMed ID: 15791570
    [Abstract] [Full Text] [Related]

  • 9. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K, Cheale M, Coleman N, Fox SB.
    Clin Cancer Res; 2002 Apr 15; 8(4):1075-81. PubMed ID: 11948116
    [Abstract] [Full Text] [Related]

  • 10. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.
    Allory Y, Matsuoka Y, Bazille C, Christensen EI, Ronco P, Debiec H.
    Clin Cancer Res; 2005 Feb 01; 11(3):1190-7. PubMed ID: 15709188
    [Abstract] [Full Text] [Related]

  • 11. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC, Barocas DA, Chen YT, Yang XJ, Scherr DS, Tu JJ.
    J Urol; 2009 May 01; 181(5):2305-11. PubMed ID: 19303095
    [Abstract] [Full Text] [Related]

  • 12. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.
    Raman JD, Mongan NP, Liu L, Tickoo SK, Nanus DM, Scherr DS, Gudas LJ.
    Carcinogenesis; 2006 Mar 01; 27(3):499-507. PubMed ID: 16344273
    [Abstract] [Full Text] [Related]

  • 13. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.
    Adley BP, Gupta A, Lin F, Luan C, Teh BT, Yang XJ.
    Am J Clin Pathol; 2006 Jul 01; 126(1):79-85. PubMed ID: 16753598
    [Abstract] [Full Text] [Related]

  • 14. mRNA expression profiles of methylated APAF-1 and DAPK-1 tumor suppressor genes uncover clear cell renal cell carcinomas with aggressive phenotype.
    Christoph F, Hinz S, Kempkensteffen C, Schostak M, Schrader M, Miller K.
    J Urol; 2007 Dec 01; 178(6):2655-9. PubMed ID: 17945286
    [Abstract] [Full Text] [Related]

  • 15. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
    Sejima T, Miyagawa I.
    Int J Urol; 2006 Mar 01; 13(3):257-64. PubMed ID: 16643620
    [Abstract] [Full Text] [Related]

  • 16. MDR1 gene expression in primary and advanced breast cancer.
    Yang X, Uziely B, Groshen S, Lukas J, Israel V, Russell C, Dunnington G, Formenti S, Muggia F, Press MF.
    Lab Invest; 1999 Mar 01; 79(3):271-80. PubMed ID: 10092063
    [Abstract] [Full Text] [Related]

  • 17. Pathologic features of renal cortical tumors.
    Tickoo SK, Gopalan A.
    Urol Clin North Am; 2008 Nov 01; 35(4):551-61; v. PubMed ID: 18992609
    [Abstract] [Full Text] [Related]

  • 18. [Non clear cell renal cell carcinoma. 2008 update in renal tumor pathology].
    Sibony M, Vieillefond A.
    Ann Pathol; 2008 Oct 01; 28(5):381-401. PubMed ID: 19068393
    [Abstract] [Full Text] [Related]

  • 19. Clinical relationship between MDR1 gene and gallbladder cancer.
    Wang BL, Zhai HY, Chen BY, Zhai SP, Yang HY, Chen XP, Zhao WT, Meng L.
    Hepatobiliary Pancreat Dis Int; 2004 May 01; 3(2):296-9. PubMed ID: 15138130
    [Abstract] [Full Text] [Related]

  • 20. Pax-2 expression in adult renal tumors.
    Daniel L, Lechevallier E, Giorgi R, Sichez H, Zattara-Cannoni H, Figarella-Branger D, Coulange C.
    Hum Pathol; 2001 Mar 01; 32(3):282-7. PubMed ID: 11274636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.